- Illustrations
- Specialized Illustrations
- Disease-specific
- Cystic Acne Subcutaneous Structure
Cystic Acne Subcutaneous Structure
Cross-sectional view of cystic acne, showing rupture of the follicle wall and subsequent severe inflammation.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Cutaneous layers are rendered in cross-section, with the epidermis superficial, the dermis intermediate, and the hypodermis (subcutaneous fat) deepest. A pilosebaceous unit traverses from the epidermal surface into the reticular dermis, with a hair shaft within the follicular canal and a sebaceous gland lobule opening into the follicular infundibulum. At the lesion site, the follicle wall is disrupted and keratinous and sebaceous contents extend beyond the follicular epithelium into the surrounding dermis and upper hypodermis, where dilated vessels and inflamed connective tissue occupy the perifollicular space. Small cutaneous nerves and vascular plexuses course inferiorly and laterally through the dermis toward the subcutaneous compartment. Follicular rupture is the key event that separates nodulocystic acne from a simple comedone, because the extrusion of keratin, sebum, and bacterial antigens into the dermis drives an intense foreign body type inflammatory reaction and can form a fluctuant pseudocyst without a true epithelial lining. Pain tracks with this anatomy. Deep inflammation at the level of the reticular dermis and subcutis explains why these lesions scar, and it also mirrors what clinicians feel on palpation when deciding between intralesional triamcinolone, systemic isotretinoin, or incision and drainage for a secondary abscess. Dermatology and pathology courses use this kind of sectional anatomy to teach lesion morphology, follicular anatomy, and the difference between inflammatory nodules, cysts, and abscesses on histologic grounds. Medical publishers can pair it with clinical photos to explain why aggressive early therapy reduces atrophic scarring and post-inflammatory hyperpigmentation by limiting dermal injury and neocollagenesis. Anatomical accuracy verified by SciePro's Medical Advisory Board.